Harbour Trust & Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6M Buy
15,533
+591
+4% +$604K 1.79% 18
2026
Q1
$13.7M Buy
14,942
+1,703
+13% +$1.73M 1.46% 24
2025
Q4
$14.2M Buy
13,239
+8,102
+158% +$7.75M 1.45% 20
2025
Q3
$3.92M Buy
5,137
+34
+0.7% +$25.3K 0.41% 61
2025
Q2
$3.98M Sell
5,103
-332
-6% -$258K 0.44% 59
2025
Q1
$4.49M Buy
5,435
+60
+1% +$49.9K 0.54% 55
2024
Q4
$4.15M Sell
5,375
-71
-1% -$58.8K 0.47% 59
2024
Q3
$4.82M Sell
5,446
-57
-1% -$51.2K 0.55% 54
2024
Q2
$4.98M Sell
5,503
-69
-1% -$55.2K 0.59% 50
2024
Q1
$4.33M Buy
5,572
+351
+7% +$250K 0.54% 59
2023
Q4
$3.04M Buy
+5,221
New +$3.05M 0.43% 61

Other funds holding LLY

Harbour Trust & Investment Management's LLY Position: Q2 2026 in Review

Harbour Trust & Investment Management increased its Eli Lilly (LLY) stake by 4% in Q2 2026, buying an estimated $604K and bringing the position to 15,533 shares worth $18.6M. The position accounts for 1.79% of the portfolio, ranked #18.

Harbour Trust & Investment Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,222 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harbour Trust & Investment Management held 15,533 shares of Eli Lilly worth $18.6M as of Q2 2026.
  • Harbour Trust & Investment Management bought 591 Eli Lilly shares in Q2 2026, an estimated $604K.
  • Eli Lilly made up 1.79% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #18 holding.
  • Harbour Trust & Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,222 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.